The company has said the treatment dramatically decreases the risk of hospitalization and death if taken within three to five days of COVID-19 symptoms appearing.
Pfizer asks FDA to approve its experimental antiviral pill for COVID-19
The company has said the treatment dramatically decreases the risk of hospitalization and death if taken within three to five days of COVID-19 symptoms appearing.